AstraZeneca Announces Positive Phase III Top-line Results for PT003 from PINNACLE 1, PINNACLE 2 Studies in COPD

By: via Benzinga
AstraZeneca (NYSE: AZN) today announced positive top-line results from the Phase III PINNACLE programme, which included two pivotal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.